nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—CMA1—hematologic cancer	0.385	0.855	CbGaD
Telaprevir—ALB—hematologic cancer	0.0333	0.074	CbGaD
Telaprevir—ABCB1—hematologic cancer	0.0318	0.0707	CbGaD
Telaprevir—ORM1—Imatinib—hematologic cancer	0.0317	0.11	CbGbCtD
Telaprevir—ABCB1—Lenalidomide—hematologic cancer	0.0155	0.0537	CbGbCtD
Telaprevir—ALB—Imatinib—hematologic cancer	0.0133	0.0461	CbGbCtD
Telaprevir—CYP3A4—Bexarotene—hematologic cancer	0.00932	0.0322	CbGbCtD
Telaprevir—ABCB1—Daunorubicin—hematologic cancer	0.00912	0.0315	CbGbCtD
Telaprevir—ABCB1—Alitretinoin—hematologic cancer	0.00893	0.0309	CbGbCtD
Telaprevir—ALB—Prednisone—hematologic cancer	0.00879	0.0304	CbGbCtD
Telaprevir—CYP3A4—Lomustine—hematologic cancer	0.00866	0.0299	CbGbCtD
Telaprevir—CYP3A4—Busulfan—hematologic cancer	0.00866	0.0299	CbGbCtD
Telaprevir—ALB—Irinotecan—hematologic cancer	0.00834	0.0288	CbGbCtD
Telaprevir—CYP3A4—Thiotepa—hematologic cancer	0.00772	0.0267	CbGbCtD
Telaprevir—ABCB1—Imatinib—hematologic cancer	0.00698	0.0241	CbGbCtD
Telaprevir—ABCB1—Nilotinib—hematologic cancer	0.00634	0.0219	CbGbCtD
Telaprevir—ABCB1—Vinorelbine—hematologic cancer	0.00629	0.0217	CbGbCtD
Telaprevir—CYP3A4—Methoxsalen—hematologic cancer	0.006	0.0207	CbGbCtD
Telaprevir—CYP3A4—Bortezomib—hematologic cancer	0.00571	0.0197	CbGbCtD
Telaprevir—ABCB1—Dasatinib—hematologic cancer	0.00561	0.0194	CbGbCtD
Telaprevir—ABCB1—Mitoxantrone—hematologic cancer	0.00554	0.0191	CbGbCtD
Telaprevir—CYP3A4—Daunorubicin—hematologic cancer	0.00546	0.0189	CbGbCtD
Telaprevir—ABCB1—Betamethasone—hematologic cancer	0.00494	0.0171	CbGbCtD
Telaprevir—ABCB1—Gemcitabine—hematologic cancer	0.00489	0.0169	CbGbCtD
Telaprevir—ABCB1—Prednisolone—hematologic cancer	0.00487	0.0168	CbGbCtD
Telaprevir—CYP3A4—Cytarabine—hematologic cancer	0.00482	0.0166	CbGbCtD
Telaprevir—CYP3A4—Teniposide—hematologic cancer	0.00475	0.0164	CbGbCtD
Telaprevir—ABCB1—Prednisone—hematologic cancer	0.0046	0.0159	CbGbCtD
Telaprevir—ALB—Methotrexate—hematologic cancer	0.00441	0.0152	CbGbCtD
Telaprevir—CYP3A4—Ifosfamide—hematologic cancer	0.00438	0.0151	CbGbCtD
Telaprevir—ABCB1—Irinotecan—hematologic cancer	0.00436	0.0151	CbGbCtD
Telaprevir—CYP3A4—Imatinib—hematologic cancer	0.00418	0.0145	CbGbCtD
Telaprevir—CYP3A4—Ruxolitinib—hematologic cancer	0.00394	0.0136	CbGbCtD
Telaprevir—ABCB1—Vinblastine—hematologic cancer	0.00388	0.0134	CbGbCtD
Telaprevir—ABCB1—Vincristine—hematologic cancer	0.00381	0.0132	CbGbCtD
Telaprevir—CYP3A4—Nilotinib—hematologic cancer	0.0038	0.0131	CbGbCtD
Telaprevir—CYP3A4—Vinorelbine—hematologic cancer	0.00377	0.013	CbGbCtD
Telaprevir—Boceprevir—CMA1—hematologic cancer	0.0037	0.924	CrCbGaD
Telaprevir—ABCB1—Cisplatin—hematologic cancer	0.00356	0.0123	CbGbCtD
Telaprevir—ABCB1—Etoposide—hematologic cancer	0.00349	0.0121	CbGbCtD
Telaprevir—CYP3A4—Triamcinolone—hematologic cancer	0.00345	0.0119	CbGbCtD
Telaprevir—CYP3A4—Dasatinib—hematologic cancer	0.00336	0.0116	CbGbCtD
Telaprevir—CYP3A4—Mitoxantrone—hematologic cancer	0.00332	0.0115	CbGbCtD
Telaprevir—CMA1—hematopoietic system—hematologic cancer	0.00331	0.0917	CbGeAlD
Telaprevir—CYP3A4—Betamethasone—hematologic cancer	0.00296	0.0102	CbGbCtD
Telaprevir—CYP3A4—Prednisolone—hematologic cancer	0.00292	0.0101	CbGbCtD
Telaprevir—ABCB1—Dexamethasone—hematologic cancer	0.00287	0.00993	CbGbCtD
Telaprevir—CYP3A4—Prednisone—hematologic cancer	0.00276	0.00953	CbGbCtD
Telaprevir—CYP3A4—Irinotecan—hematologic cancer	0.00261	0.00903	CbGbCtD
Telaprevir—ABCB1—Doxorubicin—hematologic cancer	0.00238	0.00823	CbGbCtD
Telaprevir—CYP3A4—Vinblastine—hematologic cancer	0.00232	0.00803	CbGbCtD
Telaprevir—ABCB1—Methotrexate—hematologic cancer	0.00231	0.00798	CbGbCtD
Telaprevir—CYP3A4—Vincristine—hematologic cancer	0.00228	0.00789	CbGbCtD
Telaprevir—CMA1—blood—hematologic cancer	0.0022	0.0607	CbGeAlD
Telaprevir—CTSK—hematopoietic system—hematologic cancer	0.00214	0.0591	CbGeAlD
Telaprevir—CMA1—bone marrow—hematologic cancer	0.00212	0.0588	CbGeAlD
Telaprevir—CYP3A4—Etoposide—hematologic cancer	0.00209	0.00723	CbGbCtD
Telaprevir—CMA1—lung—hematologic cancer	0.00192	0.0532	CbGeAlD
Telaprevir—CTSS—hematopoietic system—hematologic cancer	0.00187	0.0518	CbGeAlD
Telaprevir—CYP3A4—Dexamethasone—hematologic cancer	0.00172	0.00595	CbGbCtD
Telaprevir—CTSK—gonad—hematologic cancer	0.00162	0.0449	CbGeAlD
Telaprevir—CYP3A4—Doxorubicin—hematologic cancer	0.00143	0.00493	CbGbCtD
Telaprevir—CTSS—gonad—hematologic cancer	0.00142	0.0394	CbGeAlD
Telaprevir—CTSK—blood—hematologic cancer	0.00141	0.0391	CbGeAlD
Telaprevir—CTSK—bone marrow—hematologic cancer	0.00137	0.0379	CbGeAlD
Telaprevir—CMA1—lymph node—hematologic cancer	0.00132	0.0364	CbGeAlD
Telaprevir—CTSK—lung—hematologic cancer	0.00124	0.0343	CbGeAlD
Telaprevir—CTSS—blood—hematologic cancer	0.00124	0.0343	CbGeAlD
Telaprevir—CTSS—bone marrow—hematologic cancer	0.0012	0.0332	CbGeAlD
Telaprevir—CTSK—testis—hematologic cancer	0.00117	0.0324	CbGeAlD
Telaprevir—ORM1—hematopoietic system—hematologic cancer	0.00112	0.0309	CbGeAlD
Telaprevir—CTSS—lung—hematologic cancer	0.00109	0.0301	CbGeAlD
Telaprevir—CTSS—testis—hematologic cancer	0.00103	0.0284	CbGeAlD
Telaprevir—CTSK—lymph node—hematologic cancer	0.000848	0.0235	CbGeAlD
Telaprevir—CTSS—lymph node—hematologic cancer	0.000743	0.0206	CbGeAlD
Telaprevir—ORM1—blood—hematologic cancer	0.00074	0.0205	CbGeAlD
Telaprevir—ORM1—bone marrow—hematologic cancer	0.000716	0.0198	CbGeAlD
Telaprevir—ORM1—lung—hematologic cancer	0.000649	0.018	CbGeAlD
Telaprevir—ALB—testis—hematologic cancer	0.000537	0.0149	CbGeAlD
Telaprevir—CYP3A4—hematopoietic system—hematologic cancer	0.000466	0.0129	CbGeAlD
Telaprevir—ORM1—lymph node—hematologic cancer	0.000444	0.0123	CbGeAlD
Telaprevir—ALB—lymph node—hematologic cancer	0.000389	0.0108	CbGeAlD
Telaprevir—ABCB1—hematopoietic system—hematologic cancer	0.00033	0.00913	CbGeAlD
Telaprevir—CYP3A4—blood—hematologic cancer	0.000309	0.00855	CbGeAlD
Telaprevir—Boceprevir—ABCB1—hematologic cancer	0.000305	0.0763	CrCbGaD
Telaprevir—ABCB1—gonad—hematologic cancer	0.000251	0.00694	CbGeAlD
Telaprevir—ABCB1—blood—hematologic cancer	0.000219	0.00605	CbGeAlD
Telaprevir—ABCB1—bone marrow—hematologic cancer	0.000212	0.00585	CbGeAlD
Telaprevir—ABCB1—lung—hematologic cancer	0.000192	0.0053	CbGeAlD
Telaprevir—ABCB1—testis—hematologic cancer	0.000181	0.005	CbGeAlD
Telaprevir—ABCB1—lymph node—hematologic cancer	0.000131	0.00363	CbGeAlD
Telaprevir—Eye disorder—Prednisone—hematologic cancer	4.07e-05	0.00029	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Cisplatin—hematologic cancer	4.07e-05	0.00029	CcSEcCtD
Telaprevir—Vomiting—Bleomycin—hematologic cancer	4.07e-05	0.00029	CcSEcCtD
Telaprevir—Rash—Bortezomib—hematologic cancer	4.07e-05	0.00029	CcSEcCtD
Telaprevir—Dermatitis—Bortezomib—hematologic cancer	4.06e-05	0.000289	CcSEcCtD
Telaprevir—Infestation—Methotrexate—hematologic cancer	4.06e-05	0.000289	CcSEcCtD
Telaprevir—Infestation NOS—Methotrexate—hematologic cancer	4.06e-05	0.000289	CcSEcCtD
Telaprevir—Rash—Bleomycin—hematologic cancer	4.04e-05	0.000287	CcSEcCtD
Telaprevir—Dermatitis—Bleomycin—hematologic cancer	4.03e-05	0.000287	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	4.02e-05	0.000286	CcSEcCtD
Telaprevir—Asthenia—Carmustine—hematologic cancer	4.01e-05	0.000285	CcSEcCtD
Telaprevir—Vomiting—Vinorelbine—hematologic cancer	4e-05	0.000285	CcSEcCtD
Telaprevir—Diarrhoea—Thalidomide—hematologic cancer	3.98e-05	0.000283	CcSEcCtD
Telaprevir—Dizziness—Thiotepa—hematologic cancer	3.98e-05	0.000283	CcSEcCtD
Telaprevir—Asthenia—Alitretinoin—hematologic cancer	3.97e-05	0.000283	CcSEcCtD
Telaprevir—Rash—Vinorelbine—hematologic cancer	3.97e-05	0.000283	CcSEcCtD
Telaprevir—Dermatitis—Vinorelbine—hematologic cancer	3.97e-05	0.000283	CcSEcCtD
Telaprevir—Asthenia—Ifosfamide—hematologic cancer	3.92e-05	0.00028	CcSEcCtD
Telaprevir—Pruritus—Alitretinoin—hematologic cancer	3.92e-05	0.000279	CcSEcCtD
Telaprevir—Syncope—Betamethasone—hematologic cancer	3.91e-05	0.000278	CcSEcCtD
Telaprevir—Syncope—Dexamethasone—hematologic cancer	3.91e-05	0.000278	CcSEcCtD
Telaprevir—Eosinophilia—Doxorubicin—hematologic cancer	3.9e-05	0.000278	CcSEcCtD
Telaprevir—Infection—Triamcinolone—hematologic cancer	3.89e-05	0.000277	CcSEcCtD
Telaprevir—Pruritus—Ifosfamide—hematologic cancer	3.87e-05	0.000276	CcSEcCtD
Telaprevir—Shock—Triamcinolone—hematologic cancer	3.85e-05	0.000275	CcSEcCtD
Telaprevir—Dizziness—Thalidomide—hematologic cancer	3.85e-05	0.000274	CcSEcCtD
Telaprevir—Hepatobiliary disease—Methotrexate—hematologic cancer	3.84e-05	0.000273	CcSEcCtD
Telaprevir—Nausea—Bortezomib—hematologic cancer	3.83e-05	0.000273	CcSEcCtD
Telaprevir—Loss of consciousness—Betamethasone—hematologic cancer	3.83e-05	0.000273	CcSEcCtD
Telaprevir—Loss of consciousness—Dexamethasone—hematologic cancer	3.83e-05	0.000273	CcSEcCtD
Telaprevir—Asthenia—Vincristine—hematologic cancer	3.83e-05	0.000273	CcSEcCtD
Telaprevir—Vomiting—Thiotepa—hematologic cancer	3.82e-05	0.000272	CcSEcCtD
Telaprevir—Diarrhoea—Carmustine—hematologic cancer	3.82e-05	0.000272	CcSEcCtD
Telaprevir—Nausea—Bleomycin—hematologic cancer	3.8e-05	0.000271	CcSEcCtD
Telaprevir—Infestation NOS—Epirubicin—hematologic cancer	3.8e-05	0.00027	CcSEcCtD
Telaprevir—Infestation—Epirubicin—hematologic cancer	3.8e-05	0.00027	CcSEcCtD
Telaprevir—Malnutrition—Prednisone—hematologic cancer	3.79e-05	0.00027	CcSEcCtD
Telaprevir—Rash—Thiotepa—hematologic cancer	3.79e-05	0.00027	CcSEcCtD
Telaprevir—Dermatitis—Thiotepa—hematologic cancer	3.79e-05	0.00027	CcSEcCtD
Telaprevir—Diarrhoea—Alitretinoin—hematologic cancer	3.79e-05	0.00027	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	3.76e-05	0.000268	CcSEcCtD
Telaprevir—Diarrhoea—Ifosfamide—hematologic cancer	3.74e-05	0.000267	CcSEcCtD
Telaprevir—Nausea—Vinorelbine—hematologic cancer	3.74e-05	0.000266	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Etoposide—hematologic cancer	3.73e-05	0.000266	CcSEcCtD
Telaprevir—Asthenia—Mitoxantrone—hematologic cancer	3.73e-05	0.000265	CcSEcCtD
Telaprevir—Asthenia—Irinotecan—hematologic cancer	3.73e-05	0.000265	CcSEcCtD
Telaprevir—Fatigue—Etoposide—hematologic cancer	3.72e-05	0.000265	CcSEcCtD
Telaprevir—Vomiting—Thalidomide—hematologic cancer	3.7e-05	0.000263	CcSEcCtD
Telaprevir—Dizziness—Carmustine—hematologic cancer	3.69e-05	0.000263	CcSEcCtD
Telaprevir—Rash—Thalidomide—hematologic cancer	3.67e-05	0.000261	CcSEcCtD
Telaprevir—Dermatitis—Thalidomide—hematologic cancer	3.66e-05	0.000261	CcSEcCtD
Telaprevir—Dizziness—Alitretinoin—hematologic cancer	3.66e-05	0.000261	CcSEcCtD
Telaprevir—Diarrhoea—Vincristine—hematologic cancer	3.65e-05	0.00026	CcSEcCtD
Telaprevir—Asthenia—Gemcitabine—hematologic cancer	3.63e-05	0.000259	CcSEcCtD
Telaprevir—Dizziness—Ifosfamide—hematologic cancer	3.62e-05	0.000258	CcSEcCtD
Telaprevir—Urinary tract disorder—Methotrexate—hematologic cancer	3.6e-05	0.000256	CcSEcCtD
Telaprevir—Hepatobiliary disease—Epirubicin—hematologic cancer	3.59e-05	0.000256	CcSEcCtD
Telaprevir—Pruritus—Gemcitabine—hematologic cancer	3.58e-05	0.000255	CcSEcCtD
Telaprevir—Nausea—Thiotepa—hematologic cancer	3.57e-05	0.000254	CcSEcCtD
Telaprevir—Urethral disorder—Methotrexate—hematologic cancer	3.57e-05	0.000254	CcSEcCtD
Telaprevir—Diarrhoea—Mitoxantrone—hematologic cancer	3.55e-05	0.000253	CcSEcCtD
Telaprevir—Diarrhoea—Irinotecan—hematologic cancer	3.55e-05	0.000253	CcSEcCtD
Telaprevir—Vomiting—Carmustine—hematologic cancer	3.55e-05	0.000253	CcSEcCtD
Telaprevir—Infection—Dexamethasone—hematologic cancer	3.53e-05	0.000252	CcSEcCtD
Telaprevir—Infection—Betamethasone—hematologic cancer	3.53e-05	0.000252	CcSEcCtD
Telaprevir—Dizziness—Vincristine—hematologic cancer	3.53e-05	0.000251	CcSEcCtD
Telaprevir—Rash—Carmustine—hematologic cancer	3.52e-05	0.000251	CcSEcCtD
Telaprevir—Dermatitis—Carmustine—hematologic cancer	3.52e-05	0.000251	CcSEcCtD
Telaprevir—Vomiting—Alitretinoin—hematologic cancer	3.52e-05	0.000251	CcSEcCtD
Telaprevir—Infestation NOS—Doxorubicin—hematologic cancer	3.51e-05	0.00025	CcSEcCtD
Telaprevir—Infestation—Doxorubicin—hematologic cancer	3.51e-05	0.00025	CcSEcCtD
Telaprevir—Anaemia—Prednisone—hematologic cancer	3.51e-05	0.00025	CcSEcCtD
Telaprevir—Shock—Betamethasone—hematologic cancer	3.5e-05	0.000249	CcSEcCtD
Telaprevir—Shock—Dexamethasone—hematologic cancer	3.5e-05	0.000249	CcSEcCtD
Telaprevir—Rash—Alitretinoin—hematologic cancer	3.49e-05	0.000249	CcSEcCtD
Telaprevir—Nervous system disorder—Dexamethasone—hematologic cancer	3.49e-05	0.000248	CcSEcCtD
Telaprevir—Nervous system disorder—Betamethasone—hematologic cancer	3.49e-05	0.000248	CcSEcCtD
Telaprevir—Dermatitis—Alitretinoin—hematologic cancer	3.49e-05	0.000248	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	3.48e-05	0.000248	CcSEcCtD
Telaprevir—Thrombocytopenia—Betamethasone—hematologic cancer	3.48e-05	0.000248	CcSEcCtD
Telaprevir—Thrombocytopenia—Dexamethasone—hematologic cancer	3.48e-05	0.000248	CcSEcCtD
Telaprevir—Vomiting—Ifosfamide—hematologic cancer	3.48e-05	0.000248	CcSEcCtD
Telaprevir—Diarrhoea—Gemcitabine—hematologic cancer	3.46e-05	0.000247	CcSEcCtD
Telaprevir—Nausea—Thalidomide—hematologic cancer	3.45e-05	0.000246	CcSEcCtD
Telaprevir—Rash—Ifosfamide—hematologic cancer	3.45e-05	0.000246	CcSEcCtD
Telaprevir—Dermatitis—Ifosfamide—hematologic cancer	3.45e-05	0.000245	CcSEcCtD
Telaprevir—Erythema multiforme—Methotrexate—hematologic cancer	3.44e-05	0.000245	CcSEcCtD
Telaprevir—Dizziness—Irinotecan—hematologic cancer	3.43e-05	0.000245	CcSEcCtD
Telaprevir—Urticaria—Etoposide—hematologic cancer	3.43e-05	0.000244	CcSEcCtD
Telaprevir—Eye disorder—Methotrexate—hematologic cancer	3.4e-05	0.000242	CcSEcCtD
Telaprevir—Syncope—Prednisone—hematologic cancer	3.4e-05	0.000242	CcSEcCtD
Telaprevir—Vomiting—Vincristine—hematologic cancer	3.39e-05	0.000241	CcSEcCtD
Telaprevir—Urticaria—Prednisolone—hematologic cancer	3.38e-05	0.000241	CcSEcCtD
Telaprevir—Asthenia—Cisplatin—hematologic cancer	3.38e-05	0.000241	CcSEcCtD
Telaprevir—Fatigue—Triamcinolone—hematologic cancer	3.38e-05	0.000241	CcSEcCtD
Telaprevir—Urinary tract disorder—Epirubicin—hematologic cancer	3.37e-05	0.00024	CcSEcCtD
Telaprevir—Rash—Vincristine—hematologic cancer	3.36e-05	0.000239	CcSEcCtD
Telaprevir—Dermatitis—Vincristine—hematologic cancer	3.36e-05	0.000239	CcSEcCtD
Telaprevir—Oedema peripheral—Epirubicin—hematologic cancer	3.36e-05	0.000239	CcSEcCtD
Telaprevir—Urethral disorder—Epirubicin—hematologic cancer	3.34e-05	0.000238	CcSEcCtD
Telaprevir—Loss of consciousness—Prednisone—hematologic cancer	3.33e-05	0.000237	CcSEcCtD
Telaprevir—Hepatobiliary disease—Doxorubicin—hematologic cancer	3.32e-05	0.000237	CcSEcCtD
Telaprevir—Nausea—Carmustine—hematologic cancer	3.32e-05	0.000236	CcSEcCtD
Telaprevir—Vomiting—Irinotecan—hematologic cancer	3.3e-05	0.000235	CcSEcCtD
Telaprevir—Vomiting—Mitoxantrone—hematologic cancer	3.3e-05	0.000235	CcSEcCtD
Telaprevir—Nausea—Alitretinoin—hematologic cancer	3.29e-05	0.000234	CcSEcCtD
Telaprevir—Rash—Mitoxantrone—hematologic cancer	3.27e-05	0.000233	CcSEcCtD
Telaprevir—Rash—Irinotecan—hematologic cancer	3.27e-05	0.000233	CcSEcCtD
Telaprevir—Dermatitis—Mitoxantrone—hematologic cancer	3.27e-05	0.000233	CcSEcCtD
Telaprevir—Dermatitis—Irinotecan—hematologic cancer	3.27e-05	0.000233	CcSEcCtD
Telaprevir—Nausea—Ifosfamide—hematologic cancer	3.25e-05	0.000231	CcSEcCtD
Telaprevir—Diarrhoea—Cisplatin—hematologic cancer	3.23e-05	0.00023	CcSEcCtD
Telaprevir—Erythema multiforme—Epirubicin—hematologic cancer	3.22e-05	0.00023	CcSEcCtD
Telaprevir—Vomiting—Gemcitabine—hematologic cancer	3.22e-05	0.000229	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.21e-05	0.000228	CcSEcCtD
Telaprevir—Rash—Gemcitabine—hematologic cancer	3.19e-05	0.000227	CcSEcCtD
Telaprevir—Dermatitis—Gemcitabine—hematologic cancer	3.19e-05	0.000227	CcSEcCtD
Telaprevir—Eye disorder—Epirubicin—hematologic cancer	3.19e-05	0.000227	CcSEcCtD
Telaprevir—Malnutrition—Methotrexate—hematologic cancer	3.17e-05	0.000226	CcSEcCtD
Telaprevir—Nausea—Vincristine—hematologic cancer	3.17e-05	0.000226	CcSEcCtD
Telaprevir—Urinary tract disorder—Doxorubicin—hematologic cancer	3.11e-05	0.000222	CcSEcCtD
Telaprevir—Urticaria—Triamcinolone—hematologic cancer	3.11e-05	0.000222	CcSEcCtD
Telaprevir—Oedema peripheral—Doxorubicin—hematologic cancer	3.11e-05	0.000221	CcSEcCtD
Telaprevir—Dysgeusia—Methotrexate—hematologic cancer	3.1e-05	0.000221	CcSEcCtD
Telaprevir—Asthenia—Etoposide—hematologic cancer	3.1e-05	0.000221	CcSEcCtD
Telaprevir—Urethral disorder—Doxorubicin—hematologic cancer	3.09e-05	0.00022	CcSEcCtD
Telaprevir—Nausea—Mitoxantrone—hematologic cancer	3.08e-05	0.00022	CcSEcCtD
Telaprevir—Nausea—Irinotecan—hematologic cancer	3.08e-05	0.00022	CcSEcCtD
Telaprevir—Infection—Prednisone—hematologic cancer	3.08e-05	0.000219	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.07e-05	0.000219	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.07e-05	0.000219	CcSEcCtD
Telaprevir—Fatigue—Betamethasone—hematologic cancer	3.07e-05	0.000218	CcSEcCtD
Telaprevir—Fatigue—Dexamethasone—hematologic cancer	3.07e-05	0.000218	CcSEcCtD
Telaprevir—Pruritus—Etoposide—hematologic cancer	3.06e-05	0.000218	CcSEcCtD
Telaprevir—Shock—Prednisone—hematologic cancer	3.05e-05	0.000217	CcSEcCtD
Telaprevir—Nervous system disorder—Prednisone—hematologic cancer	3.04e-05	0.000216	CcSEcCtD
Telaprevir—Skin disorder—Prednisone—hematologic cancer	3.01e-05	0.000214	CcSEcCtD
Telaprevir—Nausea—Gemcitabine—hematologic cancer	3e-05	0.000214	CcSEcCtD
Telaprevir—Vomiting—Cisplatin—hematologic cancer	3e-05	0.000214	CcSEcCtD
Telaprevir—Erythema multiforme—Doxorubicin—hematologic cancer	2.98e-05	0.000212	CcSEcCtD
Telaprevir—Rash—Cisplatin—hematologic cancer	2.97e-05	0.000212	CcSEcCtD
Telaprevir—Dermatitis—Cisplatin—hematologic cancer	2.97e-05	0.000212	CcSEcCtD
Telaprevir—Malnutrition—Epirubicin—hematologic cancer	2.97e-05	0.000211	CcSEcCtD
Telaprevir—Diarrhoea—Etoposide—hematologic cancer	2.96e-05	0.000211	CcSEcCtD
Telaprevir—Eye disorder—Doxorubicin—hematologic cancer	2.95e-05	0.00021	CcSEcCtD
Telaprevir—Anaemia—Methotrexate—hematologic cancer	2.93e-05	0.000209	CcSEcCtD
Telaprevir—Dysgeusia—Epirubicin—hematologic cancer	2.91e-05	0.000207	CcSEcCtD
Telaprevir—Dizziness—Etoposide—hematologic cancer	2.86e-05	0.000203	CcSEcCtD
Telaprevir—Urticaria—Dexamethasone—hematologic cancer	2.82e-05	0.000201	CcSEcCtD
Telaprevir—Urticaria—Betamethasone—hematologic cancer	2.82e-05	0.000201	CcSEcCtD
Telaprevir—Dizziness—Prednisolone—hematologic cancer	2.82e-05	0.000201	CcSEcCtD
Telaprevir—Asthenia—Triamcinolone—hematologic cancer	2.81e-05	0.0002	CcSEcCtD
Telaprevir—Nausea—Cisplatin—hematologic cancer	2.8e-05	0.000199	CcSEcCtD
Telaprevir—Pruritus—Triamcinolone—hematologic cancer	2.77e-05	0.000197	CcSEcCtD
Telaprevir—Vomiting—Etoposide—hematologic cancer	2.75e-05	0.000196	CcSEcCtD
Telaprevir—Malnutrition—Doxorubicin—hematologic cancer	2.75e-05	0.000196	CcSEcCtD
Telaprevir—Anaemia—Epirubicin—hematologic cancer	2.74e-05	0.000195	CcSEcCtD
Telaprevir—Rash—Etoposide—hematologic cancer	2.72e-05	0.000194	CcSEcCtD
Telaprevir—Dermatitis—Etoposide—hematologic cancer	2.72e-05	0.000194	CcSEcCtD
Telaprevir—Dysgeusia—Doxorubicin—hematologic cancer	2.69e-05	0.000191	CcSEcCtD
Telaprevir—Rash—Prednisolone—hematologic cancer	2.69e-05	0.000191	CcSEcCtD
Telaprevir—Dermatitis—Prednisolone—hematologic cancer	2.68e-05	0.000191	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.68e-05	0.000191	CcSEcCtD
Telaprevir—Fatigue—Prednisone—hematologic cancer	2.67e-05	0.00019	CcSEcCtD
Telaprevir—Syncope—Epirubicin—hematologic cancer	2.66e-05	0.00019	CcSEcCtD
Telaprevir—Loss of consciousness—Epirubicin—hematologic cancer	2.61e-05	0.000186	CcSEcCtD
Telaprevir—Dizziness—Triamcinolone—hematologic cancer	2.59e-05	0.000185	CcSEcCtD
Telaprevir—Infection—Methotrexate—hematologic cancer	2.57e-05	0.000183	CcSEcCtD
Telaprevir—Nausea—Etoposide—hematologic cancer	2.57e-05	0.000183	CcSEcCtD
Telaprevir—Asthenia—Betamethasone—hematologic cancer	2.55e-05	0.000182	CcSEcCtD
Telaprevir—Asthenia—Dexamethasone—hematologic cancer	2.55e-05	0.000182	CcSEcCtD
Telaprevir—Nervous system disorder—Methotrexate—hematologic cancer	2.54e-05	0.000181	CcSEcCtD
Telaprevir—Anaemia—Doxorubicin—hematologic cancer	2.54e-05	0.000181	CcSEcCtD
Telaprevir—Thrombocytopenia—Methotrexate—hematologic cancer	2.53e-05	0.00018	CcSEcCtD
Telaprevir—Nausea—Prednisolone—hematologic cancer	2.53e-05	0.00018	CcSEcCtD
Telaprevir—Pruritus—Dexamethasone—hematologic cancer	2.52e-05	0.000179	CcSEcCtD
Telaprevir—Pruritus—Betamethasone—hematologic cancer	2.52e-05	0.000179	CcSEcCtD
Telaprevir—Skin disorder—Methotrexate—hematologic cancer	2.51e-05	0.000179	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.51e-05	0.000179	CcSEcCtD
Telaprevir—Vomiting—Triamcinolone—hematologic cancer	2.49e-05	0.000177	CcSEcCtD
Telaprevir—Rash—Triamcinolone—hematologic cancer	2.47e-05	0.000176	CcSEcCtD
Telaprevir—Dermatitis—Triamcinolone—hematologic cancer	2.47e-05	0.000176	CcSEcCtD
Telaprevir—Syncope—Doxorubicin—hematologic cancer	2.46e-05	0.000175	CcSEcCtD
Telaprevir—Urticaria—Prednisone—hematologic cancer	2.46e-05	0.000175	CcSEcCtD
Telaprevir—Diarrhoea—Dexamethasone—hematologic cancer	2.43e-05	0.000173	CcSEcCtD
Telaprevir—Diarrhoea—Betamethasone—hematologic cancer	2.43e-05	0.000173	CcSEcCtD
Telaprevir—Loss of consciousness—Doxorubicin—hematologic cancer	2.41e-05	0.000172	CcSEcCtD
Telaprevir—Infection—Epirubicin—hematologic cancer	2.41e-05	0.000171	CcSEcCtD
Telaprevir—Shock—Epirubicin—hematologic cancer	2.38e-05	0.00017	CcSEcCtD
Telaprevir—Nervous system disorder—Epirubicin—hematologic cancer	2.37e-05	0.000169	CcSEcCtD
Telaprevir—Thrombocytopenia—Epirubicin—hematologic cancer	2.37e-05	0.000169	CcSEcCtD
Telaprevir—Skin disorder—Epirubicin—hematologic cancer	2.35e-05	0.000168	CcSEcCtD
Telaprevir—Dizziness—Betamethasone—hematologic cancer	2.35e-05	0.000167	CcSEcCtD
Telaprevir—Dizziness—Dexamethasone—hematologic cancer	2.35e-05	0.000167	CcSEcCtD
Telaprevir—Nausea—Triamcinolone—hematologic cancer	2.33e-05	0.000166	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.32e-05	0.000165	CcSEcCtD
Telaprevir—Vomiting—Dexamethasone—hematologic cancer	2.26e-05	0.000161	CcSEcCtD
Telaprevir—Vomiting—Betamethasone—hematologic cancer	2.26e-05	0.000161	CcSEcCtD
Telaprevir—Rash—Dexamethasone—hematologic cancer	2.24e-05	0.00016	CcSEcCtD
Telaprevir—Rash—Betamethasone—hematologic cancer	2.24e-05	0.00016	CcSEcCtD
Telaprevir—Dermatitis—Dexamethasone—hematologic cancer	2.24e-05	0.00016	CcSEcCtD
Telaprevir—Dermatitis—Betamethasone—hematologic cancer	2.24e-05	0.00016	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.23e-05	0.000159	CcSEcCtD
Telaprevir—Fatigue—Methotrexate—hematologic cancer	2.23e-05	0.000159	CcSEcCtD
Telaprevir—Infection—Doxorubicin—hematologic cancer	2.23e-05	0.000159	CcSEcCtD
Telaprevir—Asthenia—Prednisone—hematologic cancer	2.22e-05	0.000158	CcSEcCtD
Telaprevir—Shock—Doxorubicin—hematologic cancer	2.2e-05	0.000157	CcSEcCtD
Telaprevir—Nervous system disorder—Doxorubicin—hematologic cancer	2.2e-05	0.000157	CcSEcCtD
Telaprevir—Thrombocytopenia—Doxorubicin—hematologic cancer	2.19e-05	0.000156	CcSEcCtD
Telaprevir—Pruritus—Prednisone—hematologic cancer	2.19e-05	0.000156	CcSEcCtD
Telaprevir—Skin disorder—Doxorubicin—hematologic cancer	2.18e-05	0.000155	CcSEcCtD
Telaprevir—Diarrhoea—Prednisone—hematologic cancer	2.12e-05	0.000151	CcSEcCtD
Telaprevir—Nausea—Dexamethasone—hematologic cancer	2.11e-05	0.00015	CcSEcCtD
Telaprevir—Nausea—Betamethasone—hematologic cancer	2.11e-05	0.00015	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.09e-05	0.000149	CcSEcCtD
Telaprevir—Fatigue—Epirubicin—hematologic cancer	2.09e-05	0.000149	CcSEcCtD
Telaprevir—Urticaria—Methotrexate—hematologic cancer	2.06e-05	0.000146	CcSEcCtD
Telaprevir—Dizziness—Prednisone—hematologic cancer	2.05e-05	0.000146	CcSEcCtD
Telaprevir—Vomiting—Prednisone—hematologic cancer	1.97e-05	0.00014	CcSEcCtD
Telaprevir—Rash—Prednisone—hematologic cancer	1.95e-05	0.000139	CcSEcCtD
Telaprevir—Dermatitis—Prednisone—hematologic cancer	1.95e-05	0.000139	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.93e-05	0.000138	CcSEcCtD
Telaprevir—Fatigue—Doxorubicin—hematologic cancer	1.93e-05	0.000138	CcSEcCtD
Telaprevir—Urticaria—Epirubicin—hematologic cancer	1.92e-05	0.000137	CcSEcCtD
Telaprevir—Asthenia—Methotrexate—hematologic cancer	1.86e-05	0.000132	CcSEcCtD
Telaprevir—Nausea—Prednisone—hematologic cancer	1.84e-05	0.000131	CcSEcCtD
Telaprevir—Pruritus—Methotrexate—hematologic cancer	1.83e-05	0.00013	CcSEcCtD
Telaprevir—Urticaria—Doxorubicin—hematologic cancer	1.78e-05	0.000127	CcSEcCtD
Telaprevir—Diarrhoea—Methotrexate—hematologic cancer	1.77e-05	0.000126	CcSEcCtD
Telaprevir—Asthenia—Epirubicin—hematologic cancer	1.74e-05	0.000124	CcSEcCtD
Telaprevir—Pruritus—Epirubicin—hematologic cancer	1.71e-05	0.000122	CcSEcCtD
Telaprevir—Dizziness—Methotrexate—hematologic cancer	1.71e-05	0.000122	CcSEcCtD
Telaprevir—Diarrhoea—Epirubicin—hematologic cancer	1.66e-05	0.000118	CcSEcCtD
Telaprevir—Vomiting—Methotrexate—hematologic cancer	1.65e-05	0.000117	CcSEcCtD
Telaprevir—Rash—Methotrexate—hematologic cancer	1.63e-05	0.000116	CcSEcCtD
Telaprevir—Dermatitis—Methotrexate—hematologic cancer	1.63e-05	0.000116	CcSEcCtD
Telaprevir—Asthenia—Doxorubicin—hematologic cancer	1.61e-05	0.000114	CcSEcCtD
Telaprevir—Dizziness—Epirubicin—hematologic cancer	1.6e-05	0.000114	CcSEcCtD
Telaprevir—Pruritus—Doxorubicin—hematologic cancer	1.59e-05	0.000113	CcSEcCtD
Telaprevir—Vomiting—Epirubicin—hematologic cancer	1.54e-05	0.00011	CcSEcCtD
Telaprevir—Nausea—Methotrexate—hematologic cancer	1.54e-05	0.000109	CcSEcCtD
Telaprevir—Diarrhoea—Doxorubicin—hematologic cancer	1.53e-05	0.000109	CcSEcCtD
Telaprevir—Rash—Epirubicin—hematologic cancer	1.53e-05	0.000109	CcSEcCtD
Telaprevir—Dermatitis—Epirubicin—hematologic cancer	1.53e-05	0.000109	CcSEcCtD
Telaprevir—Dizziness—Doxorubicin—hematologic cancer	1.48e-05	0.000106	CcSEcCtD
Telaprevir—Nausea—Epirubicin—hematologic cancer	1.44e-05	0.000102	CcSEcCtD
Telaprevir—Vomiting—Doxorubicin—hematologic cancer	1.42e-05	0.000101	CcSEcCtD
Telaprevir—Rash—Doxorubicin—hematologic cancer	1.41e-05	0.000101	CcSEcCtD
Telaprevir—Dermatitis—Doxorubicin—hematologic cancer	1.41e-05	0.000101	CcSEcCtD
Telaprevir—Nausea—Doxorubicin—hematologic cancer	1.33e-05	9.48e-05	CcSEcCtD
Telaprevir—CTSS—Immune System—MAPK3—hematologic cancer	7.3e-06	9.08e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTAP—hematologic cancer	7.27e-06	9.03e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	7.25e-06	9.01e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PC—hematologic cancer	7.21e-06	8.96e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EP300—hematologic cancer	7.18e-06	8.93e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	7.07e-06	8.79e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SRC—hematologic cancer	6.98e-06	8.68e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	6.97e-06	8.66e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC35B2—hematologic cancer	6.96e-06	8.65e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GBA—hematologic cancer	6.96e-06	8.65e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	6.96e-06	8.65e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—GRB2—hematologic cancer	6.9e-06	8.58e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PDGFA—hematologic cancer	6.89e-06	8.56e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	6.89e-06	8.56e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—hematologic cancer	6.8e-06	8.45e-05	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HRAS—hematologic cancer	6.78e-06	8.42e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—STAT3—hematologic cancer	6.73e-06	8.37e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NRAS—hematologic cancer	6.72e-06	8.35e-05	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	6.67e-06	8.29e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PHYH—hematologic cancer	6.66e-06	8.27e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—FTCD—hematologic cancer	6.66e-06	8.27e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GMPS—hematologic cancer	6.66e-06	8.27e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ABL1—hematologic cancer	6.63e-06	8.25e-05	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KRAS—hematologic cancer	6.56e-06	8.16e-05	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL6—hematologic cancer	6.48e-06	8.06e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—FHL2—hematologic cancer	6.48e-06	8.05e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MAPK3—hematologic cancer	6.43e-06	8e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTAP—hematologic cancer	6.37e-06	7.92e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	6.36e-06	7.91e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AGRN—hematologic cancer	6.35e-06	7.9e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	6.32e-06	7.86e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—hematologic cancer	6.26e-06	7.78e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TGFB1—hematologic cancer	6.24e-06	7.76e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HGF—hematologic cancer	6.24e-06	7.75e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	6.24e-06	7.75e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CSF2—hematologic cancer	6.17e-06	7.67e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SMPD3—hematologic cancer	6.09e-06	7.57e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	6.07e-06	7.54e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	6.06e-06	7.53e-05	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CA—hematologic cancer	6.03e-06	7.5e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—IDH2—hematologic cancer	6.02e-06	7.49e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HMMR—hematologic cancer	6.02e-06	7.49e-05	CbGpPWpGaD
Telaprevir—CTSK—Immune System—AKT1—hematologic cancer	5.98e-06	7.44e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—JAK1—hematologic cancer	5.95e-06	7.4e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PRKCG—hematologic cancer	5.95e-06	7.4e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	5.87e-06	7.3e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	5.86e-06	7.28e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	5.84e-06	7.26e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KRAS—hematologic cancer	5.78e-06	7.19e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	5.73e-06	7.12e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.68e-06	7.06e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—FHL2—hematologic cancer	5.68e-06	7.05e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ARNTL—hematologic cancer	5.66e-06	7.04e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	5.59e-06	6.94e-05	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HRAS—hematologic cancer	5.58e-06	6.94e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AGRN—hematologic cancer	5.57e-06	6.92e-05	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	5.56e-06	6.91e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IL2RA—hematologic cancer	5.56e-06	6.91e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	5.52e-06	6.86e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CA9—hematologic cancer	5.51e-06	6.85e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ACP5—hematologic cancer	5.51e-06	6.85e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NCOR2—hematologic cancer	5.44e-06	6.76e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	5.43e-06	6.75e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	5.37e-06	6.68e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PDGFB—hematologic cancer	5.37e-06	6.67e-05	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6—hematologic cancer	5.34e-06	6.64e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ASNS—hematologic cancer	5.32e-06	6.61e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—DCK—hematologic cancer	5.32e-06	6.61e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—B3GAT1—hematologic cancer	5.32e-06	6.61e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CA—hematologic cancer	5.31e-06	6.6e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	5.29e-06	6.58e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HMMR—hematologic cancer	5.28e-06	6.56e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—IDH2—hematologic cancer	5.28e-06	6.56e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CDK2—hematologic cancer	5.21e-06	6.47e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—IDH1—hematologic cancer	5.18e-06	6.44e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—hematologic cancer	5.14e-06	6.39e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCC3—hematologic cancer	5.12e-06	6.36e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TXN—hematologic cancer	5.12e-06	6.36e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTO1—hematologic cancer	5.12e-06	6.36e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	5.08e-06	6.32e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HDC—hematologic cancer	5.05e-06	6.27e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SPHK1—hematologic cancer	5.01e-06	6.23e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	5.01e-06	6.22e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MAPK14—hematologic cancer	4.99e-06	6.21e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ARNTL—hematologic cancer	4.96e-06	6.17e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	4.93e-06	6.13e-05	CbGpPWpGaD
Telaprevir—CTSS—Immune System—AKT1—hematologic cancer	4.93e-06	6.12e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HRAS—hematologic cancer	4.91e-06	6.11e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	4.87e-06	6.05e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	4.86e-06	6.04e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—FN1—hematologic cancer	4.84e-06	6.02e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CA9—hematologic cancer	4.83e-06	6e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ACP5—hematologic cancer	4.83e-06	6e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—UGT1A1—hematologic cancer	4.81e-06	5.98e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NCOR2—hematologic cancer	4.76e-06	5.92e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6—hematologic cancer	4.7e-06	5.85e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CRABP1—hematologic cancer	4.68e-06	5.82e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC22A1—hematologic cancer	4.68e-06	5.82e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CG—hematologic cancer	4.63e-06	5.76e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CDA—hematologic cancer	4.61e-06	5.74e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ALOX5—hematologic cancer	4.56e-06	5.67e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PTPN11—hematologic cancer	4.55e-06	5.66e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—IDH1—hematologic cancer	4.54e-06	5.64e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.54e-06	5.64e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.5e-06	5.59e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTO1—hematologic cancer	4.49e-06	5.58e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ABCC3—hematologic cancer	4.49e-06	5.58e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TXN—hematologic cancer	4.49e-06	5.58e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PC—hematologic cancer	4.44e-06	5.52e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NUP98—hematologic cancer	4.42e-06	5.49e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SPHK1—hematologic cancer	4.39e-06	5.46e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AKT1—hematologic cancer	4.34e-06	5.39e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CREBBP—hematologic cancer	4.29e-06	5.34e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ADCY7—hematologic cancer	4.29e-06	5.33e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NCOA3—hematologic cancer	4.29e-06	5.33e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GBA—hematologic cancer	4.29e-06	5.33e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC35B2—hematologic cancer	4.29e-06	5.33e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NUP214—hematologic cancer	4.26e-06	5.3e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.22e-06	5.24e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.22e-06	5.24e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	4.2e-06	5.22e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTR—hematologic cancer	4.17e-06	5.19e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCG2—hematologic cancer	4.17e-06	5.19e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.13e-06	5.14e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.1e-06	5.1e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CRABP1—hematologic cancer	4.1e-06	5.1e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ENO2—hematologic cancer	4.09e-06	5.09e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CD—hematologic cancer	4.07e-06	5.06e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALOX5—hematologic cancer	4e-06	4.97e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4e-06	4.97e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTT1—hematologic cancer	3.97e-06	4.94e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTAP—hematologic cancer	3.92e-06	4.88e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.91e-06	4.86e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SDC1—hematologic cancer	3.88e-06	4.82e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NUP98—hematologic cancer	3.87e-06	4.81e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3R1—hematologic cancer	3.84e-06	4.78e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ADCY7—hematologic cancer	3.76e-06	4.67e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NCOA3—hematologic cancer	3.76e-06	4.67e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—JAK2—hematologic cancer	3.74e-06	4.64e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NUP214—hematologic cancer	3.73e-06	4.64e-05	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.72e-06	4.62e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.71e-06	4.61e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTR—hematologic cancer	3.66e-06	4.55e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ABCG2—hematologic cancer	3.66e-06	4.55e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ENO2—hematologic cancer	3.59e-06	4.46e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CB—hematologic cancer	3.55e-06	4.41e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.5e-06	4.35e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—FHL2—hematologic cancer	3.5e-06	4.35e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTT1—hematologic cancer	3.48e-06	4.32e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AGRN—hematologic cancer	3.43e-06	4.26e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	3.43e-06	4.26e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SDC1—hematologic cancer	3.4e-06	4.23e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.38e-06	4.2e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NQO1—hematologic cancer	3.3e-06	4.1e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CD44—hematologic cancer	3.3e-06	4.1e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IL2—hematologic cancer	3.26e-06	4.05e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.26e-06	4.05e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—IDH2—hematologic cancer	3.25e-06	4.04e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HMMR—hematologic cancer	3.25e-06	4.04e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.23e-06	4.02e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYCS—hematologic cancer	3.12e-06	3.88e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HSP90AA1—hematologic cancer	3.1e-06	3.86e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.06e-06	3.8e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.05e-06	3.79e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CA9—hematologic cancer	2.97e-06	3.7e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ACP5—hematologic cancer	2.97e-06	3.7e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.93e-06	3.65e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—EP300—hematologic cancer	2.92e-06	3.64e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NQO1—hematologic cancer	2.89e-06	3.59e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CD44—hematologic cancer	2.89e-06	3.59e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SRC—hematologic cancer	2.84e-06	3.54e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—IDH1—hematologic cancer	2.8e-06	3.47e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.79e-06	3.47e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—hematologic cancer	2.77e-06	3.44e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.76e-06	3.44e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TXN—hematologic cancer	2.76e-06	3.44e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.76e-06	3.44e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTP1—hematologic cancer	2.75e-06	3.42e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NRAS—hematologic cancer	2.74e-06	3.4e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYCS—hematologic cancer	2.74e-06	3.4e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.72e-06	3.38e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.71e-06	3.36e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.66e-06	3.31e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MAPK3—hematologic cancer	2.62e-06	3.26e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCB1—hematologic cancer	2.61e-06	3.24e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.6e-06	3.23e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB1—hematologic cancer	2.54e-06	3.16e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTM1—hematologic cancer	2.53e-06	3.14e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NCOR1—hematologic cancer	2.53e-06	3.14e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.53e-06	3.14e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.53e-06	3.14e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.46e-06	3.06e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTP1—hematologic cancer	2.41e-06	3e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NUP98—hematologic cancer	2.39e-06	2.97e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—hematologic cancer	2.35e-06	2.93e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.32e-06	2.88e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.32e-06	2.88e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NUP214—hematologic cancer	2.3e-06	2.86e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTR—hematologic cancer	2.25e-06	2.8e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.25e-06	2.8e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTHFR—hematologic cancer	2.24e-06	2.78e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTM1—hematologic cancer	2.22e-06	2.75e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NCOR1—hematologic cancer	2.22e-06	2.75e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ENO2—hematologic cancer	2.21e-06	2.75e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CA—hematologic cancer	2.16e-06	2.69e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.14e-06	2.66e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SDC1—hematologic cancer	2.09e-06	2.6e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—hematologic cancer	2.09e-06	2.6e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HRAS—hematologic cancer	2e-06	2.49e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.97e-06	2.45e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTHFR—hematologic cancer	1.96e-06	2.43e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CG—hematologic cancer	1.88e-06	2.33e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CD44—hematologic cancer	1.78e-06	2.21e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NQO1—hematologic cancer	1.78e-06	2.21e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT1—hematologic cancer	1.77e-06	2.2e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CREBBP—hematologic cancer	1.74e-06	2.16e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYCS—hematologic cancer	1.69e-06	2.09e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.67e-06	2.08e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CD—hematologic cancer	1.65e-06	2.05e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.65e-06	2.05e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3R1—hematologic cancer	1.56e-06	1.94e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CREBBP—hematologic cancer	1.53e-06	1.9e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.49e-06	1.85e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.45e-06	1.8e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CB—hematologic cancer	1.44e-06	1.79e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALB—hematologic cancer	1.43e-06	1.77e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.41e-06	1.75e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.37e-06	1.7e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.37e-06	1.7e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.37e-06	1.7e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.26e-06	1.57e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTEN—hematologic cancer	1.24e-06	1.55e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.21e-06	1.5e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—EP300—hematologic cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTEN—hematologic cancer	1.09e-06	1.35e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—EP300—hematologic cancer	1.04e-06	1.29e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.01e-06	1.26e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.4e-07	1.17e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CD—hematologic cancer	8.91e-07	1.11e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALB—hematologic cancer	8.8e-07	1.09e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CA—hematologic cancer	8.77e-07	1.09e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.42e-07	1.05e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.77e-07	9.65e-06	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.69e-07	9.55e-06	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKT1—hematologic cancer	7.17e-07	8.91e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTEN—hematologic cancer	6.71e-07	8.34e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—EP300—hematologic cancer	6.4e-07	7.96e-06	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKT1—hematologic cancer	6.28e-07	7.8e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.74e-07	5.89e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKT1—hematologic cancer	3.87e-07	4.81e-06	CbGpPWpGaD
